Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1331725 | 1.00 | TP53 (0.44) | TP53SLC7A5GABRR1RNPEPCYP1A2 | |
| SCHEMBL9243318 | 0.86 | TP53 (0.41) | TP53SLC7A5 | |
| SCHEMBL5316544 | 0.86 | TP53 (0.50) | TP53SLC7A5GABRR1RNPEPCYP1A2 | |
| Methylmalonic Acid SCHEMBL144053 | 0.79 | TP53 (0.50) | TP53SLC7A5GABRR1RNPEPCYP1A2 | |
| Methylmalonic Acid SCHEMBL27881917 | 0.78 | TP53 (0.57) | TP53SLC7A5GABRR1RNPEPCYP1A2 | |
| Methylmalonic Acid SCHEMBL27766 | 0.78 | — | — | |
| SCHEMBL3133578 | 0.78 | FFAR3 (0.35) | TP53TSHRALDH1A1 | |
| SCHEMBL13176890 | 0.78 | TP53 (0.42) | TP53SLC7A5GABRR1RNPEPCYP1A2 | |
| SCHEMBL9127407 | 0.75 | TP53 (0.33) | TP53 | |
| SCHEMBL2994604 | 0.75 | TP53 (0.40) | TP53SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150307818-A1 | AQUEOUS CLEANER FOR THE REMOVAL OF POST-ETCH RESIDUES | ADVANCED TECH MATERIALS (US) | 2015-10-29 | — | — | US | claimed |
| CN-104710817-A | Small molecular weight coumarins near infrared fluorescent dye with large Stokes shift and synthesis method thereof | DALIAN CHEMICAL PHYSICS INST | 2015-06-17 | — | — | CN | claimed |
| US-7690783-B2 | Ink for inkjet printing, lithographic printing plate using it and method for making such plate | FUJIFILM CORPORATION (JP) | 2010-04-06 | — | — | US | claimed |
| EP-1233767-B1 | PYRUVATE ESTER COMPOSITION AND METHOD OF USE FOR RESUSCITATION AFTER EVENTS OF ISCHEMIA AND REPERFUSION | XANTHUS LIFE SCIENCES INC (CA) | 2006-04-12 | — | — | EP | claimed |
| US-20050059738-A1 | Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion | XANTHUS LIFE SCIENCES, INC. (CA) | 2005-03-17 | — | — | US | claimed |
| US-12622876-B2 | Methods of suppressing delivery of exosomes to liver and spleen | LONZA SALES AG (CH) | 2026-05-12 | — | — | US | disclosed |
| US-20250296980-A1 | EXOSOMES FOR IMMUNO-ONCOLOGY AND ANTI-INFLAMMATORY THERAPY | LONZA SALES AG (CH) | 2025-09-25 | — | — | US | disclosed |
| US-12331100-B2 | Exosomes for immuno-oncology and anti-inflammatory therapy | LONZA SALES AG (CH) | 2025-06-17 | — | — | US | disclosed |
| US-12030924-B2 | Exosomes for immuno-oncology and anti-inflammatory therapy | LONZA SALES AG (CH) | 2024-07-09 | — | — | US | disclosed |
| US-20240010705-A1 | EXOSOMES FOR IMMUNO-ONCOLOGY AND ANTI-INFLAMMATORY THERAPY | LONZA SALES AG (CH) | 2024-01-11 | — | — | US | disclosed |
| US-11512315-B2 | Methods and compositions for macrophage polarization | CODIAK BIOSCIENCES, INC. (US) | 2022-11-29 | — | — | US | disclosed |
| EP-3887016-B1 | DEFOAMING FORMULATIONS CONTAINING ORGANOPOLYSILOXANES | WACKER CHEMIE AG (DE) | 2022-06-15 | — | — | EP | disclosed |
| US-5182151-A | Polyphenylene ether, propylene graft polymer, rubber, molding material | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-01-26 | — | — | US | disclosed |
| EP-0408255-A1 | Thermoplastic resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-01-16 | — | — | EP | disclosed |
| CN-1039596-A | Preparation method in conjunction with the peptide of retroviral Protease | SMITHKLINE BECKMAN CORP (US) | 1990-02-14 | — | — | CN | disclosed |
| US-4390625-A | ERGOCORNINE AND ERGOCRYPTINE | RICHTER GEDEON VEGYESZETI GYAR RT (HU) | 1983-06-28 | — | — | US | disclosed |
| US-4377490-A | CYANOACRYLATE, ETHERS, ALCOHOLS, ACIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-03-22 | — | — | US | disclosed |
| EP-0029719-B1 | VULCANIZABLE RUBBER COMPOSITIONS INHIBITED FROM PREMATURE VULCANIZATION BY METHYLENE THIOETHERS, AND NOVEL METHYLENE THIOETHERS | MONSANTO COMPANY (US) | 1983-02-16 | — | — | EP | disclosed |
| US-4369206-A | HARDENING COATING WITH AMINES | BAYER AKTIENGESELLSCHAFT (DE) | 1983-01-18 | — | — | US | disclosed |
| US-4060626-A | Indole-carboxylic carbon compounds and pharmaceutical compositions containing them | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1977-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622876-B2 | Methods of suppressing delivery of exosomes to liver and spleen | EXOSC10, EXOSC5, EXOSC4 | TP53 2105/4885SLC7A5 465/4885GABRR1 4076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.